Your browser doesn't support javascript.
loading
Spatiotemporal Control of Vascular CaV1.2 by α1C S1928 Phosphorylation.
Martín-Aragón Baudel, Miguel; Flores-Tamez, Victor A; Hong, Junyoung; Reddy, Gopyreddy R; Maillard, Pauline; Burns, Abby E; Man, Kwun Nok Mimi; Sasse, Kent C; Ward, Sean M; Catterall, William A; Bers, Donald M; Hell, Johannes W; Nieves-Cintrón, Madeline; Navedo, Manuel F.
Affiliation
  • Martín-Aragón Baudel M; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
  • Flores-Tamez VA; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
  • Hong J; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
  • Reddy GR; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
  • Maillard P; Department of Neurology, University of California Davis, Davis, CA (P.M.).
  • Burns AE; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
  • Man KNM; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
  • Sasse KC; Sasse Surgical Associates, Reno, NV (K.C.S.).
  • Ward SM; Department of Physiology and Cell Biology, University of Nevada Reno, Reno, NV (S.M.W.).
  • Catterall WA; Department of Pharmacology, University of Washington, Seattle, WA (W.A.C.).
  • Bers DM; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
  • Hell JW; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
  • Nieves-Cintrón M; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
  • Navedo MF; Department of Pharmacology, University of California Davis, Davis, CA (M.M.-A.B., V.A.F.-T., J.H., G.R.R., A.E.B., K.N.M.M., D.M.B., J.W.H., M.N.-C., M.F.N.).
Circ Res ; 131(12): 1018-1033, 2022 12 02.
Article in En | MEDLINE | ID: mdl-36345826
ABSTRACT

BACKGROUND:

L-type CaV1.2 channels undergo cooperative gating to regulate cell function, although mechanisms are unclear. This study tests the hypothesis that phosphorylation of the CaV1.2 pore-forming subunit α1C at S1928 mediates vascular CaV1.2 cooperativity during diabetic hyperglycemia.

METHODS:

A multiscale approach including patch-clamp electrophysiology, super-resolution nanoscopy, proximity ligation assay, calcium imaging' pressure myography, and Laser Speckle imaging was implemented to examine CaV1.2 cooperativity, α1C clustering, myogenic tone, and blood flow in human and mouse arterial myocytes/vessels.

RESULTS:

CaV1.2 activity and cooperative gating increase in arterial myocytes from patients with type 2 diabetes and type 1 diabetic mice, and in wild-type mouse arterial myocytes after elevating extracellular glucose. These changes were prevented in wild-type cells pre-exposed to a PKA inhibitor or cells from knock-in S1928A but not S1700A mice. In addition, α1C clustering at the surface membrane of wild-type, but not wild-type cells pre-exposed to PKA or P2Y11 inhibitors and S1928A arterial myocytes, was elevated upon hyperglycemia and diabetes. CaV1.2 spatial and gating remodeling correlated with enhanced arterial myocyte Ca2+ influx and contractility and in vivo reduction in arterial diameter and blood flow upon hyperglycemia and diabetes in wild-type but not S1928A cells/mice.

CONCLUSIONS:

These results suggest that PKA-dependent S1928 phosphorylation promotes the spatial reorganization of vascular α1C into "superclusters" upon hyperglycemia and diabetes. This triggers CaV1.2 activity and cooperativity, directly impacting vascular reactivity. The results may lay the foundation for developing therapeutics to correct CaV1.2 and arterial function during diabetic hyperglycemia.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Hyperglycemia Limits: Animals / Humans Language: En Journal: Circ Res Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Hyperglycemia Limits: Animals / Humans Language: En Journal: Circ Res Year: 2022 Document type: Article
...